A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses

Related Experiment Video

Updated: May 23, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Marcel Krepstakies1, Julie Lucifora, Claus-Henning Nagel

  • 1Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg.

The Journal of Infectious Diseases
|March 30, 2012
PubMed

Insights

New synthetic peptides (SALPs) show broad-spectrum antiviral activity against enveloped viruses like HIV, HBV, and HCV by targeting host cells. These peptides are effective and well-tolerated, offering potential for drug-resistant infections.

Area of Science:

  • Virology
  • Drug Discovery
  • Immunology

Background:

  • Enveloped viruses, including herpesviruses, hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV), are significant human pathogens.
  • Viral coinfections are common, yet broad-spectrum antiviral therapies remain scarce.
  • Existing treatments often target specific viral components, limiting efficacy against diverse or resistant strains.

Purpose of the Study:

  • To introduce a novel class of synthetic anti-lipopolysaccharide peptides (SALPs) with broad-spectrum antiviral capabilities.
  • To investigate the potential of SALPs in inhibiting infection by multiple enveloped viruses.
  • To assess the safety and tolerability profile of SALPs.

Main Methods:

  • Development of synthetic anti-lipopolysaccharide peptides (SALPs).
  • In vitro assays to evaluate SALP efficacy against human immunodeficiency virus type 1 (HIV-1), herpes simplex virus (HSV) 1 and 2, HBV, and HCV.
  • Cell surface binding analysis to heparan sulfate moieties.
  • Toxicity and adverse effect assessments in host cells.

Main Results:

  • SALPs effectively inhibit the entry of HIV-1, HSV 1 and 2, HBV, and HCV into host cells.
  • The peptides bind to heparan sulfate moieties on the cell surface, acting as a host-targeting antiviral mechanism.
  • SALPs demonstrated high antiviral efficiency with no observed toxicity or adverse effects.

Conclusions:

  • SALPs represent a new class of broad-spectrum antiviral agents effective against a range of enveloped viruses.
  • Their mechanism of action, targeting host cell receptors, offers a promising strategy against drug-resistant viruses.
  • SALPs are well-tolerated, suggesting potential for clinical development.

More Related Videos

Engineering Antiviral Agents via Surface Plasmon Resonance13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Introduction to Virus01:28

Introduction to Virus

Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...